ANZ News
Lyrebird Health plans to scale its operation internationally, beginning in the United Kingdom.
Also, radiology reporting solutions provider Kailo Medical has acquired a clinician-founded genAI company.
Trained on two million skin images, it can perform a range of clinical tasks unlike current models.
It has shown potential to significantly reduce pain intensity.
This innovative approach, devised by the National Centre for Healthy Ageing, is expected to identify more people with dementia early.
Also, The Clinician's patient-reported measures platform is coming to Magentus' marketplace.
Emotional regulation could be the missing piece of the chronic pain treatment puzzle, says Australian researchers.
Also, TruScreen has secured a new distribution deal to reenter India.
Also, an AI-powered breath test for diagnosing silicosis has been developed in Sydney.
The training program from Edith Cowan University is expected to be released by early 2026.